Lawrence Livermore National Laboratory Immunology, inflammation and immune modulation: an overview at LLNL UCD Cancer Center - Cancer vaccine - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2011-11-02 16:54:10 Immune system Vaccination TLR9 Adjuvant Toll-like receptor Immunostimulant Immunotherapy Cancer vaccine Flagellin Medicine Biology Immunology		Lawrence Livermore National Laboratory Immunology, inflammation and immune modulation: an overview at LLNL UCD Cancer Center & Lawrence Livermore National Laboratory Annual Workshop; Livermore, CA Add to Reading List Source URL: missions.llnl.gov Download Document from Source Website File Size: 1,93 MB Share Document on Facebook

	# 3083 AGI-134, a fully synthetic α-Gal-based cancer immunotherapy that shows synergy with anti-PD-1 and favorable pre-clinical pharmacokinetic and toxicity profiles Sascha A. Kristian 1,,#, Stephen M. Shaw 1,, Kim Wi DocID: 1vdls - View Document
	Microsoft Word - ST64 Cancer Immunotherapy v1.0.docx DocID: 1uTyz - View Document
	April 18, 2018 Torii Pharmaceutical Co., Ltd. Price Listing on the NHI Reimbursement List and Launch of “CEDARCURE® Japanese Cedar Pollen Sublingual Tablets”, an Allergen Immunotherapy Tablet for Japanese Cedar Poll DocID: 1uM8x - View Document
	第42回日本免疫学会学術集会クリニカルセミナー 2 Sublingual immunotherapy for Japanese cedar pollinosis DocID: 1untY - View Document
	President of ORPHEUS Robert Adam Harris Professor in Immunotherapy in Neuroinflammation Karolinska Institutet Personal details: DocID: 1u6T9 - View Document